Nurtec ODT 75 MG tablet 8S
Ended Awarded
- Contract number
- SPE2DB25FBGPR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $105,754
Award facts
- Contract value 100% obligated
- $105,753.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $105,753.99 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) under a firm fixed price contract type. This delivery order, awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a non-set-aside competitive award to the prime contractor at its Conshohocken, Pennsylvania location. The contract falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains a significant role in federal medical procurement through its extensive portfolio of drug deliveries to the Defense Logistics Agency and its Medical Supply Chain. The company's contract awards demonstrate capability across diverse therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. NURTEC ODT (rimegepant) is a migraine treatment medication, and this delivery order fulfills military healthcare supply requirements as part of the DLA's broader pharmaceutical procurement strategy to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FBGPR?
SPE2DB25FBGPR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FBGPR worth?
The government has obligated $105,754 on SPE2DB25FBGPR.
Is contract SPE2DB25FBGPR an order under another contract?
Yes. SPE2DB25FBGPR is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBGPR competed?
The extent of competition for SPE2DB25FBGPR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award